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doi:10.1016/j.ejvs.2010.08.008Abstract Objective: To report our experience of long-term results of inframalleolar bypass.
Design: Retrospective analysis.
Materials and methods: We analysed 122 inframalleolar bypasses performed between January
1991 and June 2005 in 116 patients. Most patients were treated for critical ischaemia (97%).
The indication for the use of podalic arteries was a lack of tibial arteries with run-off to the
foot. The dorsalis pedis was predominantly used for distal anastomoses (62.3%) and the greater
saphenous vein (84.4%) as the conduit. The follow-up periods ranged from 1 to 60 months. The
endpoints analysed were graft patency, limb salvage, preservation of deambulation and
survival rate.
Results: The cumulative patency was 58.2% at 3 years and 53.4% at 5 years. The best results
were achieved with the devalvulated greater saphenous veins. Limb salvage was 70.0% at 3
years and 50.4% at 5 years, with preserved deambulation rates of 57.3% and 47.1%, respec-
tively. There were 36 major and 45 minor amputations. At 3 years, the survival rate was
50.2% and the surgical mortality 13%. Female sex was associated with worse results for cumu-
lative patency and limb salvage (P< 0.01).
Conclusions: In the long term, inframalleolar bypass is a satisfactory option for limb salvage.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
In 1959, Morris1 described the first anastomosis to the distal
popliteal artery. Since then, several reports have demon-
strated the success of this type of bypass in the treatmentCury, Servic¸o de Cirurgia
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ty for Vascular Surgery. Publisheof critical limb ischaemia (CLI).2 McCaughan3 reported
favourable results with the revascularisation of leg arteries
using autogenous veins and composite grafts. Later,
McCaughan,4 Harjola5 and Baird6 reported good results with
saphenous vein bypass grafts to the ankle and foot arteries.
Most patients with CLI, especially those with diabetes,
show extensive occlusion of the leg arteries with preser-
vation of the foot arteries, on angiographic examination.
Good clinical results have been obtained with podalic
bypasses in these patients as reported by several
groups.7e10d by Elsevier Ltd. All rights reserved.
748 F.C. Brochado Neto et al.In 2003, Pomposelli et al.11 reported a large series in
a 10-year study of bypasses to the dorsalis pedis artery,
which produced good results for limb salvage.
Recently, percutaneous transluminal angioplasty (PTA)
has been considered a feasible revascularisation method.
However, the outcomes of tibial PTA are difficult to predict
from the existing literature, because few details are given
of the intervention indications and lesion characteristics.
The objective of this report was to relate our experience
with inframalleolar bypass as an option for limb salvage,
with emphasis on the medium- and long-term results of this
procedure.Figure 1 Angiography e extensive atherosclerotic disease of
leg arteries (TASC D).Materials and methods
We conducted a retrospective analysis of 122 inframalleolar
bypasses performed in 116 patients between January 1991
and June 2005 in the Hospital do Servidor Pu´blico Estadual
de Sa˜o Paulo, in the city of Sao Paulo, Brazil. The data were
collected from the medical records of these patients.
We analysed the surgical indications, demographic data,
associated co-morbidities, surgical procedures performed
and outcomes after surgery and discharge. The main
endpoints analysed were graft patency, limb salvage,
preservation of deambulation and survival rates. All the
patients were treated for CLI (rest pain, non-healing
ulcerations or gangrene) and presented with extensive
atherosclerotic disease of the leg arteries but preservation
of the foot arteries. Since 2001, all patients have been
classified according to the TransAtlantic InterSociety
Consensus (TASC) classification. The majority of indications
were extensive arterial disease of the leg arteries (TASC C
or D; Fig. 1); patients classified as TASC A or B were pref-
erentially treated with an angioplasty method. Unfortu-
nately, angiographies performed before 2001 were not
available for analysis, so we cannot report the relevant
TASC classifications.
After discharge, graft patency was determined by
a physical examination that included palpation of the graft
and assessment of the ankleebrachial index (ABI), per-
formed either at the hospital’s clinic or at the patient’s
home. Since 1998, duplex scanning has been used for
bypass surveillance; when this method or physical exami-
nation showed any abnormality, arteriography was per-
formed. Since 2001, bypass surveillance has been
conducted in accordance with TASC.12
The medications prescribed after surgery included anti-
plaquetary drugs (aspirin 100 mg day1 or ticlopidine 500 mg
day1) and more recently, statins (simvastatin 20 mg day1).
The wounds were usually treated topically with 1% silver
sulfadiazine because it is cheap and highly effective. Most
patientswereexaminedwithangiographybefore the surgical
bypass, but post-1998, we began to use duplex map scanning
as the diagnostic method in patients with limitation in use of
contrast. This procedure was used in seven patients (6%).
Grafts were considered long when the inflow originated
from arteries above the knee, and short when they origi-
nated from arteries below it. Loupe magnification was used
for dissection and vessel anastomosis.
The statistical analysis was performed with SPSS 13.0
software (LEAD Technologies Inc.). Independent variableswere assumed to be significant if the P value was less than
0.05. Survival rates were calculated with a cumulative life
table (KaplaneMeier) with a standard error (SE) of less than
10%. The ManteleCox log-rank test was used to compare
the survival curves of different groups.
Follow-ups and statistical analysis were performed in
accordance with TASC.12
This study was approved by the hospital’s ethics
committee.
Results
The follow-up periods ranged from 1 to 60 months, with
a mean length of 25 months.
There was a predominance of males (78 men and 38
women), the mean age was 67 years (range 33e86), and the
main associated disease was diabetes mellitus (84%). Other
risk factors and associated diseases are shown in Table 1.
Surgery was indicated for CLI in 97% of patients and for
previous graft salvage in 3% (Table 2).
Primary patency was 51.4% after 3 years and 46.7% after
5 years. During this period, we performed 13 revisions of
these grafts, with a secondary patency of 58.2% (3 years)
and 53.4% (5 years; Graphic 1). Fifty-four occlusions
occurred in the 3-year period and 55 in the 5-year period.
Table 1 Demographics characteristic.
Demographics Number of patients
Age (mean; years) 67.26  10.19
Male gender 78 (67%)
Diabetes mellitus 103 (84%)
Hypertension 88 (72.1%)
Current smoker 39 (32%)
Coronary artery disease 16 (13.2%)
Congestive heart failure 16 (13.2%)
Kidney failure 11 (9%)





Greater saphenous reversed 28 (22.9%)
Greater saphenous in-situ 1 (0.8%)
Cephalic vein 5 (4.1%)
Basilic vein 2 (1.6%)
Lesser saphenous 2 (1.6%)
Composite grafts 10 (8.2%)
Inframalleolar Bypass 749Autologous veins were used in all reconstructions. When
the greater saphenous vein was unusable or had been used
previously, we preferentially used arm veins. When these
were not available, we used the lesser saphenous vein; in
these situations, the use of composite grafts was common.
The conduits are summarised in Table 3. At 3 years, we
compared the cumulative patency of bypasses made with
saphenous veins and thosemadewith alternative grafts. The
cumulative patencywas 60.4% for saphenous veins and 37.9%
for the alternative grafts, but the SE was higher than 10%.
We preferentially used non-reversed, removed devalvu-
lated veins (74 cases, 60.6%), but used reversed veins in 28
patients (22.9%) and in situ bypass in one patient. At 3 years,
the cumulative patency in the patients treatedwith reversed
veins was 60%, whereas in those treated with removed
devalvulated veins, cumulative patencywas 61.6% (PZ 0.8).
The most common distal bypass performed was below-
knee popliteal artery to dorsalis pedis artery (13 patients).
The long- and short-graft origin sites and distal anastomoses
are summarised in Table 4. For the long grafts (nZ 46)
(Fig. 2), the cumulative patency at 5 years was 55.5%; for the
short grafts (nZ 76; Fig. 3), it was 51%. These results are not
significantly different (PZ 0.87; SE< 10%).
The preoperative ABI was calculated for 90 of 122 limbs;
the mean ABI was 0.47. In 13 patients (10.7%), the ABI was
higher than 1.0, which was attributed to calcified arteries;
consequently, these were not considered.
We analysed 21 bypasses to the vicariate branches of the
foot arteries (medial plantar in 13 patients, lateral plantar in
three and tarsal lateral in 5 patients). These bypasses had
a cumulative patency of 39.6% and a limb salvage rate of 77%
at 3 years but the SE was acceptable for only six months.
In the 116 patients, 36 major amputations were per-
formed (30 below the knee and 6 above the knee) and 45
minor amputations, which did not exceed the metatarsal
level. Limb salvage was 70.0% at 3 years and 50.4% at 5
years, preserved deambulation was 57.3% and 47.1%,
respectively (Graphic 1).Table 2 Indications for surgery.
Indications Number of patients
Gangrene 68 (55.7%)
Infection 27 (22.1%)
Non-healing ulcer 17 (13.9%)
Rest pain 6 (4.9%)
Bypass salvage 4 (3.3%)In 122 operations, there were three (2.4%) graft infec-
tions, which were treated with re-intervention and graft
ligature, followed by major amputation. In all these cases,
multi-drug-resistant Staphylococcus aureus was isolated
and treated with an appropriate antibiotic, but without
success.
Univariate analysis of the demographic and clinical
factors showed that females were associated with worse
results for cumulative patency and limb salvage (Graphic 2;
Table 5). We also compared the results of bypasses in dia-
betic and non-diabetic patients; no statistical significance
was found in terms of cumulative patency and limb salvage,
but analysis of cumulative patency showed an SE of less
than 10% in the non-diabetic group (nZ 19) only until the
second month (Graphic 3; Table 5).
The patient survival rates were 50.2% at 3 years and
38.4% at 5 years. Surgical mortality was 13% (16 patients).
The follow-up rate for patients after hospital discharge
was 71.7%, including ambulatory and home visits.Discussion
It has been demonstrated in several studies13e15 that
bypasses to inframalleolar vessels are effective in limb
salvage. We examined our experience of several factors
that influence the patency of these bypasses. The
frequency of diabetic patients (84%) in our series was high.
This has previously been noted by Strandness16 as a factor
associated with the greater preservation of foot arteries
than the tibial ones.
In the present analysis of patients after 3 years, only the
female sex predicted worse results for cumulative patency
(33.8% vs. 68.4% in males; P< 0.001) and limb salvage (57.1%
vs. 77.2% in males; PZ 0.005). This finding has already been
reported and related to the presence of anti-phospholipid
antibodies, which occur more frequently in females and are
associated with the failure of bypass grafts.17 Our study was
a retrospective analysis and the identification of anti-phos-
pholipid antibodies was not the purpose of this analysis.
Preoperative angiography is important in the study of leg
and foot arteries, and we preferentially use digital angi-
ography with non-ionic contrast injected into the femoral
artery. Our second option as a diagnostic method is arterial
duplex scan mapping in patients in whom the use of
contrast is restricted. The dorsalis pedis artery is usually
the best-preserved artery in the foot, so it is the most
common site of distal anastomosis.11,12 We used this artery
in 76 (62.3%) patients.
Table 4 Inflow arteries and distal anastomoses.
Inflow arteries Number
Long bypass Common femoral 8 (6.6%)
Superficial femoral 26 (21.3%)
Above-knee popliteal 11 (9.0%)
Previous graft 7 (5.7%)
Short bypass Below-knee popliteal 52 (42.6%)
Tibial-peroneal trunk 1 (0.8%)
Anterior tibial 10 (8.2%)
Posterior tibial 7 (5.7%)
Distal anastomosis Dorsalis pedis 76 (62.3%)
Common plantar 25 (20.5%)
Medial plantar 13 (10.1%)
Lateral tarsica 5 (4.1%)
Lateral plantar 3 (2.5%)
750 F.C. Brochado Neto et al.A controversial issue debated in the literature is the
choice of a distal graft anastomosis when the leg and foot
arteries are preserved. Bergamini et al.18 prefer to use the
artery in the best condition for implantation, but this willFigure 2 Long graft bypass Femoral Common ealso depend on the extent of the trophic lesions and the
condition of the skin at the site of the incision. Pedal
arteries are situated at a superficial level, which makes
a distal anastomosis easier, and there is no difference
between using a leg or a foot artery for a distal anastomosis
when the trophic lesions are stable.19 When tissue necrosis
is worsening, it is better to use a foot artery as the target
vessel to achieve a direct pulsating blood flow.
When wet gangrene or a plantar abscess is present, anti-
biotics must be administered and all the necrotic tissues
removed before the bypass. In superficial and dry necrosis,
debridement can be performed after revascularisation.
Some patients, especially those with diabetes, may
present with rest pain or gangrene of the foot, even with an
ABI greater than 0.5. In these cases, inframalleolar revas-
cularisation could be necessary for limb salvage. This situa-
tion was observed in 48 (53%) of the present patients.
Theuseof a reversedornon-reversedvein for thebypass is
a contentious issue. When the surgical team is expert in both
techniques, the results are similar.20,21 However, we should
also consider the relative vein and artery diameters. In long
bypasses, we prefer to use non-reversed removed andDorsalis pedis with greater saphenous vein.
Figure 3 Short-graft bypass below-knee popliteal e lateral
plantar with basilic vein.
Graphic 1 Cumulative function rates of inframalleolar
bypass graft surgery (KaplaneMeier). PP, primary patency;
APP, assisted primary patency; SP, secondary patency; PD,
preserved deambulation; LS, limb salvage.
Graphic 2 Forty-eight month cumulative rates of secondary
patency (SP) and limb salvage (LS) in males and females
(KaplaneMeier; Log-Ranke P< 0.01 for SP and PZ 0.05 for LS).
Inframalleolar Bypass 751devalvulated veins.22 The advantage of this approach is that
it enables use of the best vein segments and the vein is har-
vested by staggered incisions, in contrast to the in-situ
technique. In short bypasses, the vein can be used in the
reversed position, especially considering that the saphenous
vein is narrower at the knee than in the lower third of the leg.
We found no statistical difference in the results of long and
short bypasses. Short bypasses were preferred when possible
and the best distal point on the donor artery for the proximal
anastomosis was identified, as also preferred in previousstudies.23e25 This approach avoids the dissection of the
inguinal region and allows the use of the best vein segment.
Although we used a few alternative grafts in this series
(nZ 19),26 better results were achieved with a non-
composite saphenous vein (nZ 103).
Even though surgeons carefully investigate graft patency
during follow-up, the relief of pain, trophic lesion cicatri-
sation and limb salvage are the most important targets. If
CLI disappears and if there is time for a rich collateral
circulation to form, the extremity is viable even with
eventual graft occlusion. We have found this condition at
the 3-year analysis, when the rate of limb salvage (70.5%)
was greater than the cumulative graft patency (57.8%).
After 5 years, this phenomenon was not observed (50.8%
Table 5 Univariate analysis of inframalleolar bypass graft surgery outcomes (log-rank).
Final Patency Limb Salvage












Age 69 59 3.847 0.84 0.49 59 0.908 0.62 0.22
>69 63 4.568 1 63 1.466 1
Sex Female 39 3.483 0.79 <0.001 39 1.785 1 0.005
Male 83 4.397 1 83 0.977 0.55
Hypertension No 34 1.681 0.49 0.15 34 0.927 0.74 0.47
Yes 88 3.425 1 88 1.259 1
Diabetes No 19 2.597 0.9 0.85 19 0.814 0.65 0.41
Yes 103 2.876 1 103 1.255 1
Congestive heart disease No 96 2.937 1 0.83 96 1.065 0.71 0.38
Yes 16 2.941 1 16 1.496 1
Smoking No 75 3.468 1 0.91 75 1.283 1 0.56
Yes 39 2.255 0.65 39 0.996 0.78
Distal anastomosis Dorsalis pedis 76 2.679 0.88 0.34 76 1.199 1 0.84
Others 46 3.031 1 46 1.126 0.94
Substitute GVS 19 4.184 1 0.29 19 1.073 0.90 0.86
Others 103 2.610 0.62 103 1.188 1
Graft extension
extension
Short 76 2.598 0.78 0.87 76 1.045 0.73 0.50
Long 46 3.327 1 46 1.430 1
GSV, greater saphenous vein.
752 F.C. Brochado Neto et al.limb salvage and 52.6% graft patency) but we must consider
that infections in the diabetic foot are an important cause
of limb loss. This fact was noted during analysis of limb
salvage in the non-diabetic group compared with the dia-
betic group (Graphic 3).27 Because the rate of limb salvage
was satisfactory, the preserved deambulation rate was
47.1% at 5 years and the survival rate in the same period
was only 38.4%. Our results are satisfactory and similar to
those of the large series published by Pomposelli et al.11
Percutaneous angioplasty is currently used for the treat-
ment of infrapopliteal arteries, mainly in short lesions,
classified as TASC A, B or even C. In TASC D lesions, the mainGraphic 3 Thirty-six month cumulative rates of secondary
patency (SP) and limb salvage (LS) in diabetic (DMþ) and non-
diabetic (DM) patients (KaplaneMeier).treatment is surgical bypass, as previously reported by Giles
et al.,28 who found low rates of primary patency and limb
salvage in extensive arterial disease over a period of 2 years.
Our indications were based on the TASC classification;
consequently, for TASC C and D lesions, bypass is performed
in patients with a favourable surgical risk. In patients
unsuitable for bypass (high surgical risk, lack of conduits or
good arteries for use in anastomosis), the option is endo-
vascular treatment. In many centres, the endovascular
approach is recommended as a primary approach to critical
limb ischaemia; we also consider that surgical training in
performing inframalleolar bypass is important to achieve
limb salvage in situations of endovascular failure.
Somebypasseswere implanted in the vicariate branches of
the foot arteries (lateral and medial plantar, tarsal lateral),
with an acceptable limb salvage rate at 3 years (77.0%). The
use of these branches for outflow is justified and should be
considered in patients for whom conventional surgery is not
possible, as the last chance for limb salvage.29e33
Although distal anastomosis is performed close to trophic
injuries in autogenous grafts for foot arteries, the rate of
infection observed in this situation (2.4%) was equivalent to
that associated with infrainguinal autogenous grafts.
The clinical status of surgical patients with CLI could be
reflected in the high rate of surgical mortality (13%).Conclusion
In the present series of patients, bypasses of arteries in the
foot presented satisfactory medium- and long-term rates of
patency and limb salvage, demonstrating the beneficial use
of these arteries in revascularisation for CLI. The greatest
associated risk factor was diabetes mellitus, which is
Inframalleolar Bypass 753related to the preservation of foot arteries from athero-
sclerotic disease. The female sex was associated with worse
results for cumulative patency and limb salvage. The
vicariate branches of the foot arteries could be another
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